ArticleCureus2024
The Triglyceride-Glucose Index as a Marker in Idiopathic Restless Legs Syndrome.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Restless legs syndrome (RLS) is more common in diabetic patients than in the general population. In this study, we aimed to explore the association between idiopathic RLS and the triglyceride-glucose (TyG) index, which is a simple and accessible marker of insulin resistance (IR). Materials and methods The study included 200 patients diagnosed with RLS according to the International Restless Study Group criteria, as well as 112 healthy volunteers. We interpreted the variables related to TyG and RLS by using the Pearson correlation coefficient and independent samples t-test. Multivariate linear regression analyses and receiver operating characteristic (ROC) curve analyses were employed to demonstrate the discriminatory power of the variables. Results The mean age of the patients with RLS was 44.73 ±11.29 years, and 71.5% (n=43) were female. The level of triglycerides, as well as BMI and TyG index, were significantly higher in patients with RLS compared to the control group (p=0.040, p=0.001, p=0.019, respectively). The TyG index showed a positive correlation with both disease duration (months) and BMI (r=0.281, p=0.000; r=0.507, p=0.000). The results of the multivariate regression analysis indicated a linear relationship between the TyG index and increasing RLS severity and BMI (β=0.286, t=4.199, p=0.000; β=0.041, t=6.754, p=0.000). Conclusions Our study revealed a direct correlation between the TyG index and increased disease severity, disease duration, and BMI in RLS. The findings indicate that the TyG index may serve as a valuable marker for RLS severity and high BMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.